Edition:
United Kingdom

Coherus BioSciences Inc (CHRS.OQ)

CHRS.OQ on NASDAQ Stock Exchange Global Market

20.83USD
6:53pm BST
Change (% chg)

$1.05 (+5.31%)
Prev Close
$19.78
Open
$19.75
Day's High
$20.89
Day's Low
$19.75
Volume
195,431
Avg. Vol
243,555
52-wk High
$20.89
52-wk Low
$8.34

About

Coherus BioSciences, Inc. is a late-stage clinical biologics platform company. The Company is engaged in the business of developing and commercializing biosimilar products. The Company's business is organized around therapeutic franchises, including Oncology biosimilar candidates pegfilgrastim (Neulasta) and bevacizumab... (more)

Overall

Beta: 3.45
Market Cap(Mil.): $1,372.15
Shares Outstanding(Mil.): 69.37
Dividend: --
Yield (%): --

Financials

  CHRS.OQ Industry Sector
P/E (TTM): -- 93.91 35.38
EPS (TTM): -2.66 -- --
ROI: -149.98 7.62 11.72
ROE: -- 8.12 16.38

Earnings vs. Estimates